Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Virus overrides the propensity of human CD40L-activated plasmacytoid dendritic cells to produce Th2 mediators through synergistic induction of IFN-{gamma} and Th1 chemokine production.

Bendriss-Vermare N, Burg S, Kanzler H, Chaperot L, Duhen T, de Bouteiller O, D'agostini M, Bridon JM, Durand I, Sederstrom JM, Chen W, Plumas J, Jacob MC, Liu YJ, Garrone P, Trinchieri G, Caux C, Brière F.

J Leukoc Biol. 2005 Oct;78(4):954-66. Epub 2005 Aug 4.

PMID:
16081597
2.

The transcription factor Spi-B is expressed in plasmacytoid DC precursors and inhibits T-, B-, and NK-cell development.

Schotte R, Rissoan MC, Bendriss-Vermare N, Bridon JM, Duhen T, Weijer K, Brière F, Spits H.

Blood. 2003 Feb 1;101(3):1015-23. Epub 2002 Sep 19.

PMID:
12393575
3.

Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells.

Rissoan MC, Duhen T, Bridon JM, Bendriss-Vermare N, Péronne C, de Saint Vis B, Brière F, Bates EE.

Blood. 2002 Nov 1;100(9):3295-303.

PMID:
12384430
4.

Dendritic cells directly modulate B cell growth and differentiation.

Dubois B, Bridon JM, Fayette J, Barthélémy C, Banchereau J, Caux C, Brière F.

J Leukoc Biol. 1999 Aug;66(2):224-30. Review. No abstract available.

PMID:
10449158
5.

Dendritic cells enhance the differentiation of naïve B cells into plasma cells in vitro.

Fayette J, Durand I, Bridon JM, Arpin C, Dubois B, Caux C, Liu YJ, Banchereau J, Brière F.

Scand J Immunol. 1998 Dec;48(6):563-70.

6.

CD40L activation of dendritic cells down-regulates DORA, a novel member of the immunoglobulin superfamily.

Bates EE, Dieu MC, Ravel O, Zurawski SM, Patel S, Bridon JM, Ait-Yahia S, Vega F Jr, Banchereau J, Lebecque S.

Mol Immunol. 1998 Jun;35(9):513-24.

PMID:
9809579
7.

Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites.

Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, Aït-Yahia S, Brière F, Zlotnik A, Lebecque S, Caux C.

J Exp Med. 1998 Jul 20;188(2):373-86.

8.

Identification and analysis of a novel member of the ubiquitin family expressed in dendritic cells and mature B cells.

Bates EE, Ravel O, Dieu MC, Ho S, Guret C, Bridon JM, Ait-Yahia S, Brière F, Caux C, Banchereau J, Lebecque S.

Eur J Immunol. 1997 Oct;27(10):2471-7.

PMID:
9368598
9.

Polymerase chain reaction selects a novel disintegrin proteinase from CD40-activated germinal center dendritic cells.

Mueller CG, Rissoan MC, Salinas B, Ait-Yahia S, Ravel O, Bridon JM, Briere F, Lebecque S, Liu YJ.

J Exp Med. 1997 Aug 29;186(5):655-63.

10.

Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2.

Fayette J, Dubois B, Vandenabeele S, Bridon JM, Vanbervliet B, Durand I, Banchereau J, Caux C, Brière F.

J Exp Med. 1997 Jun 2;185(11):1909-18.

11.

The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor.

Liu Y, de Waal Malefyt R, Briere F, Parham C, Bridon JM, Banchereau J, Moore KW, Xu J.

J Immunol. 1997 Jan 15;158(2):604-13.

PMID:
8992974
12.

Delayed IgG2 humoral response in infants is not due to intrinsic T or B cell defects.

Servet-Delprat C, Bridon JM, Djossou O, Yahia SA, Banchereau J, Brière F.

Int Immunol. 1996 Oct;8(10):1495-502.

PMID:
8921428
13.

Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome.

Razanajaona D, van Kooten C, Lebecque S, Bridon JM, Ho S, Smith S, Callard R, Banchereau J, Brière F.

J Immunol. 1996 Aug 15;157(4):1492-8.

PMID:
8759730
14.

IL-10-driven immunoglobulin production by B lymphocytes from IgA-deficient individuals correlates to infection proneness.

Friman V, Hanson LA, Bridon JM, Tarkowski A, Banchereau J, Brière F.

Clin Exp Immunol. 1996 Jun;104(3):432-8.

15.

Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes.

Malisan F, Brière F, Bridon JM, Harindranath N, Mills FC, Max EE, Banchereau J, Martinez-Valdez H.

J Exp Med. 1996 Mar 1;183(3):937-47.

16.

[B lymphocytes of patients with complete IgA deficiency secrete IgA in response to interleukin 10].

Brière F, Chevet D, Bridon JM, Souillet G, Rifle G, Banchereau J.

Nephrologie. 1996;17(5):289-95. French.

PMID:
8927208
17.

CD40-activated human naive surface IgD+ B cells produce IgG2 in response to activated T-cell supernatant.

Servet-Delprat C, Bridon JM, Blanchard D, Banchereau J, Brière F.

Immunology. 1995 Jul;85(3):435-41.

18.

Transforming growth factor beta (TGF beta) directs IgA1 and IgA2 switching in human naive B cells.

Briere F, Defrance T, Vanbervliet B, Bridon JM, Durand I, Rousset F, Banchereau J.

Adv Exp Med Biol. 1995;371A:21-6. No abstract available.

PMID:
8525908
19.

IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.

Fluckiger AC, Brière F, Zurawski G, Bridon JM, Banchereau J.

Immunology. 1994 Nov;83(3):397-403.

20.

Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA.

Brière F, Bridon JM, Chevet D, Souillet G, Bienvenu F, Guret C, Martinez-Valdez H, Banchereau J.

J Clin Invest. 1994 Jul;94(1):97-104.

21.

Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3.

Brière F, Servet-Delprat C, Bridon JM, Saint-Remy JM, Banchereau J.

J Exp Med. 1994 Feb 1;179(2):757-62.

22.

IL-10 and IL-13 as B cell growth and differentiation factors.

Brière F, Bridon JM, Servet C, Rousset F, Zurawski G, Banchereau J.

Nouv Rev Fr Hematol. 1993 Jun;35(3):233-5.

PMID:
7687769

Supplemental Content

Loading ...
Support Center